Genmab — April 2017

[forsent]

Ok, mange tak for svaret. Så det er et fase I..?

[E_L]

great Darvin, thanks

[E_L]

@forsent http://www.genmab.com/product-pipeline/products-in-developme
nt/humax-axl-adc

[E_L]

Welcome to Genmab

(www.genmab.com)

[bibob]

Ser ud til at investorerne er bange for at sidde udenfor inden påske, og salgstal.

[Helge_LarsenPI-redaktør]

Efter kursfaldet kan vi nu konstantere at gulvet i 1.240 er stærkt og aktien flot holder sig i den langsigtede stigende trend.

[E_L]

@ Bulder - SANJAI KUMAR‏ @TOSANJAIKUMAR :
"Daratumumab is available in India for patients with relapse and refractory to both PI and IMiDs in multiple myeloma."

[Helge_LarsenPI-redaktør]

Multiple Myeloma Survival  in India by Priya Menon and Gary Petersen

India has 1.24 billion people, or a population that is nearly 4 times greater than the USA.  The USA has nearly 22,000 newly diagnosed patients with multiple myeloma, and the best information I...

Multiple Myeloma - Survival Rate Statistics by Hospital (myelomasurvival.com)

[Bulder]

Tak E L. Dvs at det er monoterapi i 4. linje.

[Darvin]

Ved ikke om denne har været nævnt - Syros og Dara. http://finance.yahoo.com/news/syros-presents-data-aacr-further-120100400.html?soc_src=social-sh&soc_trk=tw https://clinicaltrials.gov/ct2/show/NCT02807558?term=syros&rank=1

[Budweis]

patenthaj

• http://uniqueconsult.dk/en/patent-attorney/

[Helge_LarsenPI-redaktør]

1.278.

[bibob]

Er vi tilfredse.

[bibob]

Jeg svarer selv. Yes.

[ienk1]

Jeg mangler ca 200,-)

[ienk1]

[bibob]

Ja men kun tilfreds for i dag. IKK.

[Mogan]

Enig jenk1 & bibob

[royal]

Nu ved vi hvor bunden er. Så skal vi have fundet toppen.

[ienk1]

Infinity